Spyre Therapeutics, Inc.
SYRE
23 insider filings · Latest: Jun 25, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Apr 4 1:29 AM | Scott L BurrowsChief Financial Officer | Sale | 7,500 | $49.34 | $370.1K | 97,994(D) | View → |
| Apr 1, 2026 | Apr 1 8:38 PM | SHELDON SLOAN | Proposed Sale | 7,958 | $50.44 | $401.4K | — | View → |
| Mar 3, 2026 | Mar 4 2:32 AM | Scott L BurrowsChief Financial Officer | Sale | 2,500 | $40.65 | $101.6K | 97,994(D) | View → |
| Mar 2, 2026 | Mar 4 2:31 AM | Cameron TurtleDirector, Chief Executive Officer | Sale | 15,000 | $42.19 | $632.9K | 642,540(D) | View → |
| Mar 3, 2026 | Mar 3 9:43 PM | SCOTT BURROWS | Proposed Sale | 10,000 | $42.49 | $424.9K | — | View → |
| Mar 2, 2026 | Mar 2 9:31 PM | CAMERON TURTLE | Proposed Sale | 60,000 | $43.01 | $2.6M | — | View → |
| Feb 2, 2026 | Feb 5 2:33 AM | Cameron TurtleDirector, Chief Executive Officer | Sale | 15,000 | $32.80 | $492.0K | 657,540(D) | View → |
| Nov 3, 2025 | Nov 3 9:24 PM | CAMERON TURTLE | Proposed Sale | 90,000 | $24.46 | $2.2M | — | View → |
| Oct 25, 2024 | Oct 25 8:28 PM | SESSIONS, LLC | Proposed Sale | 7,000 | $33.70 | $235.9K | — | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | Jun 27 1:31 AM | Scott L BurrowsChief Financial Officer | Option Exercise | 15,000 | $14.50 | 359,857(D) | View → |
| Jun 23, 2026 | Jun 24 1:56 AM | Fairmount Funds Management LLCDirector | Conversion | 16,667 | — | 0(I) | View → |
| Jun 3, 2026 | Jun 4 1:32 AM | Sheldon SloanChief Medical Officer | Option Exercise | 8,333 | $27.46 | 313,334(D) | View → |
| Jun 1, 2026 | Jun 4 1:30 AM | Scott L BurrowsChief Financial Officer | Option Exercise | 7,500 | $14.50 | 374,857(D) | View → |
| May 27, 2026 | May 29 9:58 PM | Fairmount Funds Management LLCDirector | Grant/Award | 8,026 | $72.51 | 8,026(I) | View → |
| May 27, 2026 | May 29 9:56 PM | Jeffrey W. AlbersDirector | Grant/Award | 8,026 | $72.51 | 8,026(D) | View → |
| May 27, 2026 | May 29 9:55 PM | Michael Thomas HendersonDirector | Grant/Award | 8,026 | $72.51 | 8,026(D) | View → |
| May 27, 2026 | May 29 9:55 PM | Laurie StelzerDirector | Grant/Award | 8,026 | $72.51 | 8,026(D) | View → |
| May 27, 2026 | May 29 9:55 PM | Mark C. MckennaDirector | Grant/Award | 8,026 | $72.51 | 8,026(D) | View → |
| May 27, 2026 | May 29 9:54 PM | Sandra MilliganDirector | Grant/Award | 8,026 | $72.51 | 8,026(D) | View → |
| May 1, 2026 | May 2 1:35 AM | Scott L BurrowsChief Financial Officer | Option Exercise | 12,500 | $14.50 | 382,357(D) | View → |
| May 1, 2026 | May 2 1:34 AM | Sheldon SloanChief Medical Officer | Option Exercise | 78,333 | $27.46 | 321,667(D) | View → |
| Apr 1, 2026 | Apr 4 1:30 AM | Sheldon SloanChief Medical Officer | Option Exercise | 7,958 | $21.66 | 87,542(D) | View → |
| Apr 1, 2026 | Apr 4 1:29 AM | Scott L BurrowsChief Financial Officer | Option Exercise | 7,500 | $14.50 | 394,857(D) | View → |
| Mar 3, 2026 | Mar 4 2:32 AM | Scott L BurrowsChief Financial Officer | Option Exercise | 2,500 | $14.50 | 402,357(D) | View → |